These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15645847)

  • 21. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastro-intestinal stromal tumour--role of CD117 in diagnosis and management.
    Paul PC; Chakraborty J; Kundu D; Sarkar R
    Indian J Pathol Microbiol; 2007 Apr; 50(2):279-83. PubMed ID: 17883045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal stromal tumor in Brazil: clinicopathology, immunohistochemistry, and molecular genetics of 513 cases.
    Lopes LF; Ojopi EB; Bacchi CE
    Pathol Int; 2008 Jun; 58(6):344-52. PubMed ID: 18477213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of CD117, CD34, SMA, S-100 protein, Vim and desmin in patients with gastrointestinal stromal tumors].
    Liu J; Liu YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):438-40. PubMed ID: 18359707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MESENCHYMAL TUMOURS OF THE GASTROINTESTINAL TRACT: THE IMPORTANCE AND USE OF IMMUNHISTOCHEMISTRY IN CHARACTERIZING SPECIFIC TUMOUR ENTITIES.
    Ogun GO
    Niger J Med; 2015; 24(2):150-4. PubMed ID: 26353426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superficial leiomyomas of the gastrointestinal tract with interstitial cells of Cajal.
    Janevska V; Qerimi A; Basheska N; Stojkova E; Janevski V; Jovanovic R; Zhivadinovik J; Spasevska L
    Int J Clin Exp Pathol; 2015; 8(12):15977-84. PubMed ID: 26884872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-kit mutations in gastrointestinal stromal tumours.
    Morey AL; Wanigesekera GD; Hawkins NJ; Ward RL
    Pathology; 2002 Aug; 34(4):315-9. PubMed ID: 12190287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal stromal tumors express ras oncogene: a potential role for diagnosis and treatment.
    Blair SL; Al-Refaie WB; Wang-Rodriguez J; Behling C; Ali MW; Moossa AR
    Arch Surg; 2005 Jun; 140(6):543-7; discussion 547-8. PubMed ID: 15967901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of microscopic gastrointestinal stromal tumors in the stomach.
    Kawanowa K; Sakuma Y; Sakurai S; Hishima T; Iwasaki Y; Saito K; Hosoya Y; Nakajima T; Funata N
    Hum Pathol; 2006 Dec; 37(12):1527-35. PubMed ID: 16996566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall.
    Lam MM; Corless CL; Goldblum JR; Heinrich MC; Downs-Kelly E; Rubin BP
    Int J Gynecol Pathol; 2006 Jul; 25(3):288-92. PubMed ID: 16810068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The diagnostic and predictive role of kit (CD117)].
    Dirnhofer S; Zimpfer A; Went P
    Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor.
    Liu FY; Qi JP; Xu FL; Wu AP
    World J Gastroenterol; 2006 Jul; 12(26):4161-5. PubMed ID: 16830365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
    Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
    Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Histopathological and cytological findings in a case of gastrointestinal stromal tumor presenting in the pelvic cavity].
    Takekawa Y; Kimura M; Sakakibara M; Yoshii R; Yamashita Y
    Rinsho Byori; 2007 Jun; 55(6):535-9. PubMed ID: 17657986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
    Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
    Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
    Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
    Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD117 and carries a favourable prognosis.
    Bates AW; Feakins RM; Scheimberg I
    Histopathology; 2000 Oct; 37(4):316-22. PubMed ID: 11012738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenging differential diagnosis of a wild-type gastrointestinal stromal tumour (GIST) or rare reticular perineurioma of the stomach? The role for mutational analysis.
    Richter KK; Dempster A; Tos AP; Premkumar R; Jackson C
    N Z Med J; 2011 Mar; 124(1331):45-55. PubMed ID: 21725412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.